206 related articles for article (PubMed ID: 31663187)
1. The role of metacognition and its indirect effect through cognitive attentional syndrome on fear of cancer recurrence trajectories: A longitudinal study.
Ng DWL; Foo CC; Ng SSM; Kwong A; Suen D; Chan M; Or A; Chun OK; Fielding BFS; Lam WWT
Psychooncology; 2020 Feb; 29(2):271-279. PubMed ID: 31663187
[TBL] [Abstract][Full Text] [Related]
2. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
[TBL] [Abstract][Full Text] [Related]
3. Psychological factors associated with clinical fear of cancer recurrence in breast cancer patients in the early survivorship period.
Waroquier P; Delevallez F; Razavi D; Merckaert I
Psychooncology; 2022 Nov; 31(11):1877-1885. PubMed ID: 35674194
[TBL] [Abstract][Full Text] [Related]
4. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence.
Butow P; Kelly S; Thewes B; Hruby G; Sharpe L; Beith J
Psychooncology; 2015 Apr; 24(4):416-23. PubMed ID: 25156065
[TBL] [Abstract][Full Text] [Related]
5. Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.
Sharpe L; Turner J; Fardell JE; Thewes B; Smith AB; Gilchrist J; Beith J; Girgis A; Tesson S; Day S; Grunewald K; Butow P;
J Cancer Surviv; 2019 Oct; 13(5):695-702. PubMed ID: 31347010
[TBL] [Abstract][Full Text] [Related]
6. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism.
Ng DWL; Kwong A; Suen D; Chan M; Or A; Ng SS; Foo CC; Fielding BFS; Lam WWT
Psychooncology; 2019 Jun; 28(6):1243-1251. PubMed ID: 30932279
[TBL] [Abstract][Full Text] [Related]
7. Towards the validation of a new, blended theoretical model of fear of cancer recurrence.
Lebel S; Maheu C; Tomei C; Bernstein LJ; Courbasson C; Ferguson S; Harris C; Jolicoeur L; Lefebvre M; Muraca L; Ramanakumar AV; Singh M; Parrott J; Figueiredo D
Psychooncology; 2018 Nov; 27(11):2594-2601. PubMed ID: 30180279
[TBL] [Abstract][Full Text] [Related]
8. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
Thewes B; Bell ML; Butow P
Psychooncology; 2013 Sep; 22(9):2059-63. PubMed ID: 23408595
[TBL] [Abstract][Full Text] [Related]
9. The association between metacognition, coping style and fear of cancer recurrence among postmastectomy patients: A cross sectional study.
Zhang H; Lin Z; Li T; Kong M; Li J; Wu W; He Z
Eur J Oncol Nurs; 2023 Dec; 67():102460. PubMed ID: 37951072
[TBL] [Abstract][Full Text] [Related]
10. Fear of cancer recurrence in colorectal cancer survivors.
Custers JAE; Gielissen MFM; Janssen SHV; de Wilt JHW; Prins JB
Support Care Cancer; 2016 Feb; 24(2):555-562. PubMed ID: 26108170
[TBL] [Abstract][Full Text] [Related]
11. Study protocol: a randomized controlled trial comparing the efficacy of therapist guided internet-delivered cognitive therapy (TG-iConquerFear) with augmented treatment as usual in reducing fear of cancer recurrence in Danish colorectal cancer survivors.
Lyhne JD; Smith A'B; Frostholm L; Fink P; Jensen LH
BMC Cancer; 2020 Mar; 20(1):223. PubMed ID: 32178640
[TBL] [Abstract][Full Text] [Related]
12. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
Hovdenak Jakobsen I; Jeppesen MM; Simard S; Thaysen HV; Laurberg S; Juul T
J Cancer Surviv; 2018 Dec; 12(6):723-732. PubMed ID: 30128857
[TBL] [Abstract][Full Text] [Related]
13. Predictors and patterns of fear of cancer recurrence in breast cancer survivors.
McGinty HL; Small BJ; Laronga C; Jacobsen PB
Health Psychol; 2016 Jan; 35(1):1-9. PubMed ID: 26030308
[TBL] [Abstract][Full Text] [Related]
14. Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer.
Maheu C; Hébert M; Louli J; Yao TR; Lambert S; Cooke A; Black A; Kyriacou J
Cancer Rep (Hoboken); 2019 Aug; 2(4):e1172. PubMed ID: 32721129
[TBL] [Abstract][Full Text] [Related]
15. Validity and screening capacity of the FCR-1r for fear of cancer recurrence in long-term colorectal cancer survivors.
Lyhne JD; Smith AB; Timm S; Simard S; Jensen LH; Frostholm L; Fink P
Support Care Cancer; 2023 Nov; 31(12):690. PubMed ID: 37950072
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial.
van de Wal M; Thewes B; Gielissen M; Speckens A; Prins J
J Clin Oncol; 2017 Jul; 35(19):2173-2183. PubMed ID: 28471726
[TBL] [Abstract][Full Text] [Related]
17. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
[TBL] [Abstract][Full Text] [Related]
18. Re-validation and screening capacity of the 6-item version of the Cancer Worry Scale.
Custers JAE; Kwakkenbos L; van de Wal M; Prins JB; Thewes B
Psychooncology; 2018 Nov; 27(11):2609-2615. PubMed ID: 29843189
[TBL] [Abstract][Full Text] [Related]
19. Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
Deuning-Smit E; Custers JAE; Miroševič Š; Takes RP; Jansen F; Langendijk JA; Terhaard CHJ; Baatenburg de Jong RJ; Leemans CR; Smit JH; Kwakkenbos L; Verdonck-de Leeuw IM; Prins JB
Head Neck; 2022 Apr; 44(4):914-925. PubMed ID: 35084079
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the validity and screening performance of a revised single-item fear of cancer recurrence screening measure (FCR-1r).
Smith A'; Gao M; Tran M; Ftanou M; Jegathees S; Wu V; Jefford M; Lynch F; Dhillon HM; Shaw J; McDowell L; White A; Halloran C; Wiesenfeld D; Bamgboje-Ayodele A
Psychooncology; 2023 Jun; 32(6):961-971. PubMed ID: 37120796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
